Error: Could not add to watchlist. X

NuPathe Inc

+ Watchlist
PATH:US
Acquired
PATH:US was acquired by TEVA:IT
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.21
Market Cap (USD)
-
Shares Outstanding (m)
31.329
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
NuPathe Inc. develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. The Company offers various medicines for migraines, Parkinson's, schizophrenia, and other cognitive disorders.
ADDRESS
227 Washington Street
Suite 200
Conshohocken, PA 19428
United States
PHONE
1-484-567-0130
  • Richard S Egosi
    President/CEO/Director
  • Deborah A Griffin
    VP/CFO/Treasurer
Show More